Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis

Cardiovasc Diabetol. 2018 Feb 20;17(1):31. doi: 10.1186/s12933-018-0675-2.

Abstract

Background: Clinical complications associated with atherosclerotic plaques arise from luminal obstruction due to plaque growth or destabilization leading to rupture. We previously demonstrated that overexpression of insulin receptor isoform A (IRA) and insulin-like growth factor-I receptor (IGF-IR) confers a proliferative and migratory advantage to vascular smooth muscle cells (VSMCs) promoting plaque growth in early stages of atherosclerosis. However, the role of insulin receptor (IR) isoforms, IGF-IR or insulin-like growth factor-II receptor (IGF-IIR) in VSMCs apoptosis during advanced atherosclerosis remains unclear.

Methods: We evaluated IR isoforms expression in human carotid atherosclerotic plaques by consecutive immunoprecipitations of insulin receptor isoform B (IRB) and IRA. Western blot analysis was performed to measure IGF-IR, IGF-IIR, and α-smooth muscle actin (α-SMA) expression in human plaques. The expression of those proteins, as well as the presence of apoptotic cells, was analyzed by immunohistochemistry in experimental atherosclerosis using BATIRKO; ApoE-/- mice, a model showing more aggravated vascular damage than ApoE-/- mice. Finally, apoptosis of VSMCs bearing IR (IRLoxP+/+ VSMCs), or not (IR-/- VSMCs), expressing IRA (IRA VSMCs) or expressing IRB (IRB VSMCs), was assessed by Western blot against cleaved caspase 3.

Results: We observed a significant decrease of IRA/IRB ratio in human complicated plaques as compared to non-complicated regions. Moreover, complicated plaques showed a reduced IGF-IR expression, an increased IGF-IIR expression, and lower levels of α-SMA indicating a loss of VSMCs. In experimental atherosclerosis, we found a significant decrease of IRA with an increased IRB expression in aorta from 24-week-old BATIRKO; ApoE-/- mice. Furthermore, atherosclerotic plaques from BATIRKO; ApoE-/- mice had less VSMCs content and higher number of apoptotic cells. In vitro experiments showed that IGF-IR inhibition by picropodophyllin induced apoptosis in VSMCs. Apoptosis induced by thapsigargin was lower in IR-/- VSMCs expressing higher IGF-IR levels as compared to IRLoxP+/+ VSMCs. Finally, IRB VSMCs are more prone to thapsigargin-induced apoptosis than IRA or IRLoxP+/+ VSMCs.

Conclusions: In advanced human atherosclerosis, a reduction of IRA/IRB ratio, decreased IGF-IR expression, or increased IGF-IIR may contribute to VSMCs apoptosis, promoting plaque instability and increasing the risk of plaque rupture and its clinical consequences.

Keywords: Apoptosis; Atherosclerosis; Insulin receptor isoforms; Insulin-like growth factor receptor; Vascular smooth muscle cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Animals
  • Antigens, CD / metabolism
  • Aorta, Thoracic / metabolism
  • Aorta, Thoracic / pathology
  • Aortic Diseases / genetics
  • Aortic Diseases / metabolism*
  • Aortic Diseases / pathology
  • Apoptosis
  • Carotid Arteries / metabolism
  • Carotid Arteries / pathology
  • Carotid Artery Diseases / metabolism*
  • Carotid Artery Diseases / pathology
  • Cell Line
  • Disease Models, Animal
  • Female
  • Humans
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout, ApoE
  • Middle Aged
  • Muscle, Smooth, Vascular / metabolism*
  • Muscle, Smooth, Vascular / pathology
  • Myocytes, Smooth Muscle / metabolism
  • Myocytes, Smooth Muscle / pathology
  • Plaque, Atherosclerotic*
  • Protein Isoforms
  • Receptor, IGF Type 1 / metabolism
  • Receptor, IGF Type 2 / metabolism
  • Receptor, Insulin / metabolism*
  • Receptors, Somatomedin / metabolism*
  • Rupture, Spontaneous

Substances

  • Antigens, CD
  • IGF1R protein, human
  • Protein Isoforms
  • Receptor, IGF Type 2
  • Receptors, Somatomedin
  • INSR protein, human
  • Receptor, IGF Type 1
  • Receptor, Insulin